These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24978141)

  • 1. Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.
    Seo S; Xie H; Karron RA; Thumar B; Englund JA; Leisenring WM; Stevens-Ayers T; Boeckh M; Campbell AP
    Bone Marrow Transplant; 2014 Sep; 49(9):1205-11. PubMed ID: 24978141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F; Alvares C; Riley U; Ethell M; Cunningham D; Treleaven J; Ashley S; Bendig J; Morgan G; Potter M
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children.
    Waghmare A; Wagner T; Andrews R; Smith S; Kuypers J; Boeckh M; Moss R; Englund JA
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):114-8. PubMed ID: 26185620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Canti L; Humblet-Baron S; Desombere I; Neumann J; Pannus P; Heyndrickx L; Henry A; Servais S; Willems E; Ehx G; Goriely S; Seidel L; Michiels J; Willems B; Liston A; Ariën KK; Beguin Y; Goossens ME; Marchant A; Baron F
    J Hematol Oncol; 2021 Oct; 14(1):174. PubMed ID: 34689821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome.
    Seo S; Xie H; Campbell AP; Kuypers JM; Leisenring WM; Englund JA; Boeckh M
    Clin Infect Dis; 2014 May; 58(10):1357-68. PubMed ID: 24599766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
    Nichols WG; Corey L; Gooley T; Davis C; Boeckh M
    Blood; 2001 Aug; 98(3):573-8. PubMed ID: 11468152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
    Chakrabarti S; Collingham KE; Holder K; Oyaide S; Pillay D; Milligan DW
    Clin Infect Dis; 2000 Dec; 31(6):1516-8. PubMed ID: 11096028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
    Salvatore M; Satlin MJ; Jacobs SE; Jenkins SG; Schuetz AN; Moss RB; Van Besien K; Shore T; Soave R
    Biol Blood Marrow Transplant; 2016 May; 22(5):965-70. PubMed ID: 26904972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation.
    Srinivasan A; Wang C; Yang J; Shenep JL; Leung WH; Hayden RT
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1520-7. PubMed ID: 21396476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
    Peck AJ; Englund JA; Kuypers J; Guthrie KA; Corey L; Morrow R; Hackman RC; Cent A; Boeckh M
    Blood; 2007 Sep; 110(5):1681-8. PubMed ID: 17502457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission pattern of parainfluenza 3 virus in guinea pig breeding herds.
    Blomqvist GA; Martin K; Morein B
    Contemp Top Lab Anim Sci; 2002 Jul; 41(4):53-7. PubMed ID: 12109899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes.
    Kim YJ; Waghmare A; Xie H; Holmberg L; Pergam SA; Jerome KR; Leisenring WM; Ogimi C; Campbell AP; Englund JA; Boeckh M
    Blood Adv; 2022 Sep; 6(18):5307-5316. PubMed ID: 35446933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.
    Sorror ML; Logan BR; Zhu X; Rizzo JD; Cooke KR; McCarthy PL; Ho VT; Horowitz MM; Pasquini MC
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1479-87. PubMed ID: 25862591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.
    Casey J; Morris K; Narayana M; Nakagaki M; Kennedy GA
    Bone Marrow Transplant; 2013 Nov; 48(12):1558-61. PubMed ID: 23912665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.
    Hodson A; Kasliwal M; Streetly M; MacMahon E; Raj K
    Bone Marrow Transplant; 2011 Dec; 46(12):1545-50. PubMed ID: 21258418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to parainfluenza virus type 3 in goat population in Poland.
    Moroz A; Czopowicz M; Mickiewicz M; Witkowski L; Szaluś-Jordanow O; Nalbert T; Klimowicz-Bodys MD; Markowska-Daniel I; Bagnicka E; Kaba J
    Pol J Vet Sci; 2021 Jun; 24(2):235-241. PubMed ID: 34250778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.